452 related articles for article (PubMed ID: 25355878)
1. APOBEC3A functions as a restriction factor of human papillomavirus.
Warren CJ; Xu T; Guo K; Griffin LM; Westrich JA; Lee D; Lambert PF; Santiago ML; Pyeon D
J Virol; 2015 Jan; 89(1):688-702. PubMed ID: 25355878
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.
Westrich JA; Warren CJ; Klausner MJ; Guo K; Liu CW; Santiago ML; Pyeon D
J Virol; 2018 Apr; 92(7):. PubMed ID: 29367246
[TBL] [Abstract][Full Text] [Related]
3. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions.
Vartanian JP; Guétard D; Henry M; Wain-Hobson S
Science; 2008 Apr; 320(5873):230-3. PubMed ID: 18403710
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B.
Vieira VC; Leonard B; White EA; Starrett GJ; Temiz NA; Lorenz LD; Lee D; Soares MA; Lambert PF; Howley PM; Harris RS
mBio; 2014 Dec; 5(6):. PubMed ID: 25538195
[TBL] [Abstract][Full Text] [Related]
5. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
[TBL] [Abstract][Full Text] [Related]
6. APOBEC3A Expression in Penile Squamous Cell Carcinoma.
Heller M; Prigge ES; Kaczorowski A; von Knebel Doeberitz M; Hohenfellner M; Duensing S
Pathobiology; 2018; 85(3):169-178. PubMed ID: 29166639
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14.
Cicchini L; Westrich JA; Xu T; Vermeer DW; Berger JN; Clambey ET; Lee D; Song JI; Lambert PF; Greer RO; Lee JH; Pyeon D
mBio; 2016 May; 7(3):. PubMed ID: 27143385
[TBL] [Abstract][Full Text] [Related]
8. Role of the host restriction factor APOBEC3 on papillomavirus evolution.
Warren CJ; Van Doorslaer K; Pandey A; Espinosa JM; Pyeon D
Virus Evol; 2015 Jan; 1(1):. PubMed ID: 27570633
[TBL] [Abstract][Full Text] [Related]
9. Loss of Dependence on Continued Expression of the Human Papillomavirus 16 E7 Oncogene in Cervical Cancers and Precancerous Lesions Arising in Fanconi Anemia Pathway-Deficient Mice.
Park S; Park JW; Pitot HC; Lambert PF
mBio; 2016 May; 7(3):. PubMed ID: 27190216
[TBL] [Abstract][Full Text] [Related]
10. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.
Guidry JT; Myers JE; Bienkowska-Haba M; Songock WK; Ma X; Shi M; Nathan CO; Bodily JM; Sapp MJ; Scott RS
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381489
[TBL] [Abstract][Full Text] [Related]
12. Combined Transcriptome and Proteome Analysis of Immortalized Human Keratinocytes Expressing Human Papillomavirus 16 (HPV16) Oncogenes Reveals Novel Key Factors and Networks in HPV-Induced Carcinogenesis.
Yang R; Klimentová J; Göckel-Krzikalla E; Ly R; Gmelin N; Hotz-Wagenblatt A; Řehulková H; Stulík J; Rösl F; Niebler M
mSphere; 2019 Mar; 4(2):. PubMed ID: 30918060
[TBL] [Abstract][Full Text] [Related]
13. APOBEC3A possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer.
Chen S; Li X; Qin J; Chen Y; Liu L; Zhang D; Wang M; Wang M; Zhang D
Int J Clin Exp Med; 2015; 8(7):10548-57. PubMed ID: 26379844
[TBL] [Abstract][Full Text] [Related]
14. Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism.
Lee JH; Yi SM; Anderson ME; Berger KL; Welsh MJ; Klingelhutz AJ; Ozbun MA
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):2094-9. PubMed ID: 14769917
[TBL] [Abstract][Full Text] [Related]
15. APOBEC3: Friend or Foe in Human Papillomavirus Infection and Oncogenesis?
Warren CJ; Santiago ML; Pyeon D
Annu Rev Virol; 2022 Sep; 9(1):375-395. PubMed ID: 35671565
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the HA3 subcomponent of Clostridium botulinum type C progenitor toxin.
Nakamura T; Kotani M; Tonozuka T; Ide A; Oguma K; Nishikawa A
J Mol Biol; 2009 Jan; 385(4):1193-206. PubMed ID: 19071137
[TBL] [Abstract][Full Text] [Related]
17. E6/E7 and E6
Artaza-Irigaray C; Molina-Pineda A; Aguilar-Lemarroy A; Ortiz-Lazareno P; Limón-Toledo LP; Pereira-Suárez AL; Rojo-Contreras W; Jave-Suárez LF
Front Immunol; 2019; 10():1676. PubMed ID: 31396215
[TBL] [Abstract][Full Text] [Related]
18. Effect of Productive Human Papillomavirus 16 Infection on Global Gene Expression in Cervical Epithelium.
Kang SD; Chatterjee S; Alam S; Salzberg AC; Milici J; van der Burg SH; Meyers C
J Virol; 2018 Oct; 92(20):. PubMed ID: 30045992
[TBL] [Abstract][Full Text] [Related]
19. APOBEC3A associates with human papillomavirus genome integration in oropharyngeal cancers.
Kondo S; Wakae K; Wakisaka N; Nakanishi Y; Ishikawa K; Komori T; Moriyama-Kita M; Endo K; Murono S; Wang Z; Kitamura K; Nishiyama T; Yamaguchi K; Shigenobu S; Muramatsu M; Yoshizaki T
Oncogene; 2017 Mar; 36(12):1687-1697. PubMed ID: 27694899
[TBL] [Abstract][Full Text] [Related]
20. High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression.
Reiser J; Hurst J; Voges M; Krauss P; Münch P; Iftner T; Stubenrauch F
J Virol; 2011 Nov; 85(21):11372-80. PubMed ID: 21849431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]